Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 100,000 shares at $76.53 ($7.6M) on 2019-02-27, disclosed to the SEC on 2019-03-01.
Open-market sale of $7.6M GHDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.53 | 22,807 | $1.7M | 22.8% |
| 2 | $76.53 | 22,807 | $1.7M | 22.8% |
| 3 | $77.29 | 2,193 | $169K | 2.2% |
| 4 | $77.29 | 2,193 | $169K | 2.2% |
| 5 | $75.62 | 5,302 | $401K | 5.2% |
| 6 | $75.62 | 5,302 |
| $401K |
| 5.2% |
| 7 | $76.41 | 14,900 | $1.1M | 14.9% |
| 8 | $76.41 | 14,900 | $1.1M | 14.9% |
| 9 | $77.22 | 4,798 | $370K | 4.8% |
| 10 | $77.22 | 4,798 | $371K | 4.8% |
| Total | $76.50 avg | 100,000 | $7.6M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |